RHX-829

N/A

Report date: 2023/12/19 14:31:59
NME

Base Information

Drug NameRHX-829
Drug Alias NameRHX-829
ClassificationOther
Mechanisms of ActionT lymphocytes inhibitors
TargetsNot applicable
Therapy Area/IndicationsInflammatory Bowel DiseasesArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRheos Medicines Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsInflammatory Bowel DiseasesArthritis, Rheumatoid
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A